je.st
news
Galapagos, GSK successfully conclude phase 2a study of skin disease drug
2014-04-17 09:46:53| Biotech - Topix.net
Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.
Tags: study
skin
drug
phase
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|